Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Jiangsu Hansoh Pharmaceutical Group Co., Ltd., commonly referred to as Hansoh Pharmaceutical, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Jiangsu, China. Founded in 1995, the company has established a strong presence in both domestic and international markets, focusing on innovative drug development and production.
Hansoh Pharmaceutical is renowned for its diverse portfolio, which includes oncology, central nervous system, and anti-infective medications. The company’s commitment to research and development has led to several key milestones, positioning it as a significant contributor to the pharmaceutical landscape. With a robust pipeline of unique products, Hansoh continues to enhance its market position, earning recognition for its quality and efficacy in addressing critical health needs.
-3 vs industry average
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.’s score of 39 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Jiangsu Hansoh Pharmaceutical Group Co., Ltd. yet.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd., a pharmaceutical preparation manufacturer based in CN, does not have publicly available carbon emissions data. However, as a current subsidiary of Hansoh Pharmaceutical Group Company Limited, its climate-related initiatives and performance data are cascaded from its parent company. While specific emissions figures for Jiangsu Hansoh Pharmaceutical Group Co., Ltd. are unavailable, its climate commitments would align with those of Hansoh Pharmaceutical Group Company Limited.
No climate goals have been disclosed for Jiangsu Hansoh Pharmaceutical Group Co., Ltd. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more